06.09.2024 18:00:00

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, September 6, 2024Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

The transactions concern the sale of shares following a recent exercise of warrants granted to members of the executive management as part of incentive programs launched in 2019 and 2020. The net gain from these transactions is subject to taxation, and thus a significant part of the sale is executed to off-set tax obligations. After these transactions, the net holdings of shares in Bavarian Nordic for members of the executive management has increased.

1.Details of the person discharging managerial responsibilities/person closely associated  
a)NamePaul John Chaplin
2.Reason for the notification
a)Position/statusPresident and Chief Executive Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Shares


DK0015998017
b)Nature of the transactionSale
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 243.802798,855
d)Aggregated information
  • Aggregated volume
  • Price
 

98,855
DKK 24,101,115.91
e)Date of the transaction2024-09-06
f)Place of the transactionNasdaq Copenhagen A/S, XCSE


1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameHenrik Juuel
2.Reason for the notification
a)Position/statusExecutive Vice President and Chief Financial Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Shares


DK0015998017
b)Nature of the transactionSale
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 243.802734,416
d)Aggregated information
  • Aggregated volume
  • Price
 

34,416
DKK 8,390,713.72
e)Date of the transaction2024-09-06
f)Place of the transactionNasdaq Copenhagen A/S, XCSE


1.Details of the person discharging managerial responsibilities/person closely associated  
a)NameJean-Christophe May
2.Reason for the notification
a)Position/statusExecutive Vice President and Chief Commercial Officer of Bavarian Nordic A/S
b)Initial notification/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameBavarian Nordic A/S
b)LEI2138006JCDVYIN6INP51
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument


Identification code
Shares


DK0015998017
b)Nature of the transactionSale
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 243.80277,039
d)Aggregated information
  • Aggregated volume
  • Price
 

7,039
DKK 1,716,127.21
e)Date of the transaction2024-09-06
f)Place of the transactionNasdaq Copenhagen A/S, XCSE

About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, rss@bavarian-nordic.com, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

Company Announcement no. 29 / 2024

Attachment


Analysen zu Bavarian Nordic A/Smehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Bavarian Nordic A/S 25,60 0,31% Bavarian Nordic A/S